🇺🇸 FDA
Patent

US 9944926

Induced exon inclusion in spinal muscle atrophy

granted A61PA61P21/02A61P25/00

Quick answer

US patent 9944926 (Induced exon inclusion in spinal muscle atrophy) held by Sarepta Therapeutics, Inc. expires Mon Apr 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sarepta Therapeutics, Inc.
Grant date
Tue Apr 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61P, A61P21/02, A61P25/00